These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26732706)

  • 21. Integrated screening for Down's syndrome.
    Chen FM
    J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
    Morris JK; Bestwick J; Wald NJ
    J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal genetic diagnosis of Down's syndrome.
    Abbott MA; Benn P
    Expert Rev Mol Diagn; 2002 Nov; 2(6):605-15. PubMed ID: 12465456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between maternal hepatitis B virus carrier status and Down's syndrome prenatal screening indicators and their effects on the screening results.
    Huang L; Chen Y; Ning W; Chen Y; Yu D
    J Obstet Gynaecol; 2022 Oct; 42(7):2793-2798. PubMed ID: 36036240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does screening for Down's syndrome cause anxiety in pregnant women? A systematic review.
    Lou S; Mikkelsen L; Hvidman L; Petersen OB; Nielsen CP
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):15-27. PubMed ID: 25146713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome.
    Boyd PA; Devigan C; Khoshnood B; Loane M; Garne E; Dolk H;
    BJOG; 2008 May; 115(6):689-96. PubMed ID: 18410651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
    Spencer K; Carpenter P
    BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B; Rodeck CH
    Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
    Palomaki GE; Neveux LM; Haddow JE
    J Med Screen; 1996; 3(1):12-7. PubMed ID: 8861045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
    Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
    BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down's syndrome screening: a controversial test, with more controversy to come!
    Reynolds TM
    J Clin Pathol; 2000 Dec; 53(12):893-8. PubMed ID: 11265172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A.
    Spencer K
    BJOG; 2001 Oct; 108(10):1043-6. PubMed ID: 11702835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.